| Serial Number | 79320193 |
| Word Mark | XCUBE |
| Filing Date | Thursday, February 25, 2021 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Monday, September 25, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; none of the foregoing in connection with HVAC systems or components thereof |
| Pseudo Mark | X CUBE |
| Goods and Services | Compilation of statistical data and models with respect to cancer treatment and cancer diagnosis |
| Goods and Services | Medical and pharmaceutical consultancy services |
| Goods and Services | Computer programming in the medical, pharmaceutical and biotechnological field; database design in the medical, pharmaceutical and biotechnological field; maintenance of database software in the medical, pharmaceutical, and biotechnological field; programming of software for importing and managing data in the medical, pharmaceutical, and biotechnological field; information technology [IT] consulting services for the pharmaceutical and healthcare industries; computer programming for data processing; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; providing scientific molecular and genomic information for medical and clinical research, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology; none of the foregoing in connection with HVAC systems or components thereof |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Immatics Biotechnologies GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Friday, March 29, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 25, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, September 25, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, March 14, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, February 27, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, February 22, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 22, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, January 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 30, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, November 28, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, November 2, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, November 2, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 2, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 2, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, November 2, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 7, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, May 13, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, May 13, 2022 | LETTER OF SUSPENSION E-MAILED |
| Friday, May 13, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, May 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 10, 2022 | ASSIGNED TO LIE |
| Friday, May 6, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, November 29, 2021 | REFUSAL PROCESSED BY IB |
| Monday, November 8, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 8, 2021 | REFUSAL PROCESSED BY MPU |
| Thursday, October 14, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, October 13, 2021 | SUSPENSION LETTER WRITTEN |
| Thursday, October 7, 2021 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Friday, September 24, 2021 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 22, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 21, 2021 | SUSPENSION LETTER WRITTEN |
| Tuesday, September 21, 2021 | ASSIGNED TO EXAMINER |
| Monday, September 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 16, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |